News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
News Industry News TCT 2016 Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents November 02, 2016
News Conference News TCT 2016 TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES Michael O'Riordan November 02, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
News Industry News TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies October 31, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2016 DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term Todd Neale October 30, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Daily News “Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos Michael O'Riordan August 01, 2016
News Daily News ‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed Michael O'Riordan August 01, 2016
News Daily News Study Supports Noninferiority of Dedicated Bifurcation Stent: But is That Good Enough for Adoption? Todd Neale July 08, 2016
News Daily News Thin-Cap Fibroatheromas May Help Explain Poor PCI Outcomes in Diabetic Patients Todd Neale July 06, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016